Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Thursday, August 16, 2018 · 458,832,614 Articles · 3+ Million Readers

Global In-Vitro Diagnostics Market 2018 - Industry Analysis, Size, Share, Strategies and Forecast to 2020

PUNE, INDIA, March 9, 2018 /EINPresswire.com/ -- Global In-Vitro Diagnostics Industry

Latest Report on In-Vitro Diagnostics Market Global Analysis & 2020 Forecast Research Study

Global In-Vitro diagnostics market has been estimated at USD 59.45 billion in 2015 and is expected to reach 78.07 billion at a Compound Annual Growth Rate (CAGR) of 5.6%. In-Vitro diagnostics can be described as tests that can help in detecting diseases, conditions or infections. Some of these tests are performed in laboratory or healthcare settings while other tests are for consumers to use at home.

Try Sample Report @   https://www.wiseguyreports.com/sample-request/635489-in-vitro-diagnostics-market-forecasts-2015-2020

In-Vitro diagnostics test a sample of tissue or body fluids for microbial cultures or blood glucose. They are also used for testing changes in the liver function, imbalance in calcium levels in the body and electrolytes in the blood such as sodium, urea, potassium and Creatinine. The end users of In Vitro diagnostics market are generally Laboratories, Hospitals, Academic institutions, Point-of-care testing centers. There are around 40,000 IVD products available in the market assisting patients and specialists on a wide range of conditions

Global In-Vitro Diagnostics market is expected to witness faster growth owing to advancements and innovations in the IVD technologies. Rising geriatric population base, growing prevalence of diabetes are the key factors driving the growth of the market. Increasing recognition of the diabetic’s role in the patient care and rapidly evolving healthcare environment due to growing awareness about various diseases are expected to drive the In-Vitro market in the forecast period. However stringent regulatory policies and unclear reimbursement policies are restraining the growth of the market.

Global market for In-Vitro Diagnostics is segmented by product, by technology and by application. On the basis of product the market is again sub segmented into instruments, reagents and kits, Data management system/software and services. On the basis of technology the in-vitro diagnostics market is sub segmented into Clinical Chemistry, Hematology, immunoassays, Coagulation and Hemostasis, molecular diagnostics, microbiology and other IVD technologies. On the basis of application the market for In-Vitro diagnostics is segmented into Diabetes, Infectious Diseases, Oncology/Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug testing and HIV

On the basis of geography global market for In-Vitro diagnostics is segmented into North America, Asia-Pacific, Europe, Latin America and Middle-East & Africa. North America Is the largest market for In-Vitro diagnostics accounting for a share of around 37% owing to growing prevalence of chronic diseases such as cancer and respiratory diseases in the region while Asia-Pacific is estimated to be the fastest growing segment with a CAGR of 6.4%.

Abbott Laboratories, Johnson and Johnson, Siemens Healthcare, Becton Dickinson, Roche Diagnostics, and Beckman Coulter Inc. are the major players dominating the global IVD market. Other companies which account for a significant share in the IVD market are Biomérieux, Ortho Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Sysmex Corporation and Thermo Fisher Scientific, Inc.

For Detailed Reading Please visit WiseGuy Reports @     https://www.wiseguyreports.com/reports/635489-in-vitro-diagnostics-market-forecasts-2015-2020

Some points from table of content:

Introduction 
1.1 Market Definition 
1.2 Study Deliverables 
1.3 Base Currency, Base Year and Forecast Periods 
1.4 General Study Assumptions 
2. Research Methodology 
2.1 Introduction 
2.2 Research Phases 
2.2.1 Secondary Research 
2.2.2 Primary Research 
2.2.3 Econometric Modelling 
2.2.4 Expert Validation 
2.3 Analysis Design 
2.4 Study Timeline 
3. Overview 
3.1 Executive Summary 
3.2 Key Inferences 
3.3 New Developments 
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 
4.1 Market Drivers 
4.2 Market Restraints 
4.3 Key Challenges 
4.4 Current Opportunities in the Market 
5. Market Segmentation 
5.1 By Product 
5.1.1 Instruments 
5.1.2 Reagents and Kits 
5.1.3 Software 
5.2 By Technology 
5.2.1 Clinical Chemistry 
5.2.2 Hematology 
5.2.3 Immunoassays 
5.2.4 Coagulation and Hemostasis 
5.2.5 Molecular Diagnostics 
5.2.6 Microbiology 
5.2.7 Other IVD technologies 
5.3 By Application 
5.3.1 Diabetes 
5.3.2 Infectious Diseases 
5.3.3 Oncology/Cancer 
5.3.4 Cardiology 
5.3.5 Nephrology 
5.3.6 Autoimmune Diseases 
5.3.7 Drug Testing 
5.3.8 HIV 
6. Geographical Analysis 
6.1 North America 
6.1.1 Introduction 
6.1.2 United States 
6.1.3 Canada 
6.2 Europe 
6.2.1 Introduction 
6.2.2 U.K 

Continued…….

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire